BR112022017436A2 - Composição para uso em um tratamento de anormalidades de célula cervical - Google Patents
Composição para uso em um tratamento de anormalidades de célula cervicalInfo
- Publication number
- BR112022017436A2 BR112022017436A2 BR112022017436A BR112022017436A BR112022017436A2 BR 112022017436 A2 BR112022017436 A2 BR 112022017436A2 BR 112022017436 A BR112022017436 A BR 112022017436A BR 112022017436 A BR112022017436 A BR 112022017436A BR 112022017436 A2 BR112022017436 A2 BR 112022017436A2
- Authority
- BR
- Brazil
- Prior art keywords
- acid
- composition
- cervical cell
- cell abnormalities
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20160817.1A EP3875083A1 (en) | 2020-03-03 | 2020-03-03 | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid |
| PCT/EP2021/055230 WO2021175877A1 (en) | 2020-03-03 | 2021-03-03 | Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022017436A2 true BR112022017436A2 (pt) | 2022-10-18 |
Family
ID=69770560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022017436A BR112022017436A2 (pt) | 2020-03-03 | 2021-03-03 | Composição para uso em um tratamento de anormalidades de célula cervical |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20230092142A1 (https=) |
| EP (2) | EP3875083A1 (https=) |
| JP (1) | JP7840859B2 (https=) |
| CN (1) | CN115279358A (https=) |
| AR (1) | AR122387A1 (https=) |
| AU (1) | AU2021231205B2 (https=) |
| BR (1) | BR112022017436A2 (https=) |
| CL (1) | CL2022002363A1 (https=) |
| CY (1) | CY1126764T1 (https=) |
| ES (1) | ES2976058T3 (https=) |
| HR (1) | HRP20240374T1 (https=) |
| HU (1) | HUE066384T2 (https=) |
| IL (1) | IL296146A (https=) |
| MA (1) | MA58262B1 (https=) |
| MD (1) | MD4084788T2 (https=) |
| MX (1) | MX2022010838A (https=) |
| PL (1) | PL4084788T3 (https=) |
| RS (1) | RS65349B1 (https=) |
| SM (1) | SMT202400126T1 (https=) |
| TW (1) | TW202146004A (https=) |
| UA (1) | UA130108C2 (https=) |
| WO (1) | WO2021175877A1 (https=) |
| ZA (1) | ZA202208848B (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2406377C (en) | 2000-05-10 | 2010-07-06 | Okopharm Forschungs-Und Entwicklungs-Gmbh | Method for reducing the surface area of silicon dioxide |
| AT412758B (de) | 2000-06-05 | 2005-07-25 | Vis Vitalis Lizenz & Handels | Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen |
| AT412703B (de) | 2001-12-04 | 2005-06-27 | Vis Vitalis Lizenz & Handels | Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung |
| AT511159A1 (de) * | 2011-02-16 | 2012-09-15 | Selo Medical Gmbh | Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen |
| EP3616693A1 (en) * | 2018-08-28 | 2020-03-04 | Selo Medical GmbH | Therapy of high-risk human papillomavirus infections |
-
2020
- 2020-03-03 EP EP20160817.1A patent/EP3875083A1/en not_active Withdrawn
-
2021
- 2021-02-20 TW TW110105956A patent/TW202146004A/zh unknown
- 2021-03-02 AR ARP210100542A patent/AR122387A1/es unknown
- 2021-03-03 MX MX2022010838A patent/MX2022010838A/es unknown
- 2021-03-03 ES ES21709400T patent/ES2976058T3/es active Active
- 2021-03-03 MA MA58262A patent/MA58262B1/fr unknown
- 2021-03-03 IL IL296146A patent/IL296146A/en unknown
- 2021-03-03 HU HUE21709400A patent/HUE066384T2/hu unknown
- 2021-03-03 UA UAA202203621A patent/UA130108C2/uk unknown
- 2021-03-03 JP JP2022551024A patent/JP7840859B2/ja active Active
- 2021-03-03 BR BR112022017436A patent/BR112022017436A2/pt unknown
- 2021-03-03 PL PL21709400.2T patent/PL4084788T3/pl unknown
- 2021-03-03 CN CN202180017791.7A patent/CN115279358A/zh active Pending
- 2021-03-03 SM SM20240126T patent/SMT202400126T1/it unknown
- 2021-03-03 RS RS20240372A patent/RS65349B1/sr unknown
- 2021-03-03 EP EP21709400.2A patent/EP4084788B1/en active Active
- 2021-03-03 WO PCT/EP2021/055230 patent/WO2021175877A1/en not_active Ceased
- 2021-03-03 HR HRP20240374TT patent/HRP20240374T1/hr unknown
- 2021-03-03 AU AU2021231205A patent/AU2021231205B2/en active Active
- 2021-03-03 MD MDE20221247T patent/MD4084788T2/ro unknown
- 2021-03-03 US US17/905,145 patent/US20230092142A1/en active Pending
-
2022
- 2022-08-08 ZA ZA2022/08848A patent/ZA202208848B/en unknown
- 2022-08-30 CL CL2022002363A patent/CL2022002363A1/es unknown
-
2024
- 2024-03-27 CY CY20241100221T patent/CY1126764T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230092142A1 (en) | 2023-03-23 |
| EP3875083A1 (en) | 2021-09-08 |
| RS65349B1 (sr) | 2024-04-30 |
| CL2022002363A1 (es) | 2023-03-31 |
| JP7840859B2 (ja) | 2026-04-06 |
| ES2976058T3 (es) | 2024-07-22 |
| EP4084788A1 (en) | 2022-11-09 |
| WO2021175877A1 (en) | 2021-09-10 |
| CY1126764T1 (el) | 2026-02-25 |
| ZA202208848B (en) | 2024-09-25 |
| AU2021231205A1 (en) | 2022-09-01 |
| CN115279358A (zh) | 2022-11-01 |
| EP4084788B1 (en) | 2024-02-14 |
| TW202146004A (zh) | 2021-12-16 |
| CA3167015A1 (en) | 2021-09-10 |
| AU2021231205B2 (en) | 2026-02-26 |
| MD4084788T2 (ro) | 2024-06-30 |
| IL296146A (en) | 2022-11-01 |
| MA58262B1 (fr) | 2024-03-29 |
| PL4084788T3 (pl) | 2024-06-03 |
| UA130108C2 (uk) | 2025-11-12 |
| JP2023516153A (ja) | 2023-04-18 |
| AR122387A1 (es) | 2022-09-07 |
| HUE066384T2 (hu) | 2024-07-28 |
| SMT202400126T1 (it) | 2024-05-14 |
| EP4084788C0 (en) | 2024-02-14 |
| MX2022010838A (es) | 2022-09-27 |
| HRP20240374T1 (hr) | 2024-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lin et al. | Randomized, controlled trial comparing the efficacy of intrauterine balloon and intrauterine contraceptive device in the prevention of adhesion reformation after hysteroscopic adhesiolysis | |
| Vollman | The menstrual cycle | |
| WO2008096122A3 (en) | Progesterone for the prevention of preterm birth | |
| Emechebe | Determinants and complications of pre-labour rupture of membranes (PROM) at the University of Calabar Teaching Hospital (UCTH), Calabar, Nigeria | |
| BR112022017436A2 (pt) | Composição para uso em um tratamento de anormalidades de célula cervical | |
| US20210128514A1 (en) | Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker | |
| KR960705560A (ko) | 산화질소 합성효소 기질 및(또는) 공여체, 또는 산화질소 저해제를 사용한 자궁 수축성 질환의 치료 방법(Treatment of Uterine Contractility Disorders with a Nitric Oxide Synthase Substrate and/or Donor, or a Nitric Oxide Inhibitor) | |
| Blackfield et al. | Congenital contricting bands of the extremities | |
| GUNTHER et al. | Systemic Scleroderma in Pregnancy: Report of a Case | |
| Patel et al. | Comparison of the efficacy and safety of norethisterone vs. combined oral contraceptive pills for the management of puberty menorrhagia | |
| Tien et al. | Cervical ectopic pregnancy: persistence despite a serologically negative β-hCG. A case report | |
| Castallo | Bilateral simultaneous tubal pregnancy: Paola, Guillermo Di, and Ibanez, Anibal Lemos: Bol. Soc. de Obst. y ginec.(Buenos Aires) 14: 837, 1936 | |
| Goldberger | Complete tubal abortion from columnar implantation of the ovum: Hoffman, AI: Gynéc. et obst. 33: 520, 1936 | |
| WO2013160914A1 (en) | Novel synergistic composition comprising of a carotenoid, serm and an amino acid derivative thereof | |
| Palasová et al. | Heterotopic pregnancy Vital intrauterine pregnancy 12+ 4, vital ectopic pregnancy 11+ 4 | |
| Van der Westhuizen et al. | The safety and efficacy of low-dose oral contraceptives: CPD article | |
| RU2578478C1 (ru) | Способ профилактики преждевременных родов | |
| Haynes | Shirodkar operation in habitual abortion: Antoine: p. 122 | |
| UA145642U (uk) | Спосіб профілактики перинатальних ускладнень при невиношуванні в ранні терміни вагітності | |
| CN118987066A (zh) | 一种口腔抗炎组合物及其制备方法和应用 | |
| Khan et al. | Role of micronized progesterone in women with arrested Preterm labor | |
| Witherspoon | Extra-uterine pregnancy following the injection of iodized oil for uterosalpingography: Polowe, David: Am. J. Surg. 29: 244, 1935 | |
| CN116785334A (zh) | 一种治疗肛门直肠疾病的中药组合物及其应用 | |
| Spielman | Pregnancy and delivery with an intrauterine pessary in the cervix: Welton, TS, and Ellingson, O.: Am. J. Surg. 54: 484, 1941 | |
| Pemberton | Leucorrhea| Hinselmann: Ztschr. f. Geburtsh. u. Gynäk. 93: 349, 1928 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |